Spectrum Health names new chief medical officer

Grand Rapids, Michigan-based Spectrum Health Hospital Group has named Darryl Elmouchi, MD, MBA, chief medical officer, effective Oct. 10.

Elmouchi, who has worked at Spectrum since 2010, was previously the cardiovascular division chief.

As CMO, Elmouchi will assist in developing the hospital group’s strategic plan, which includes clinical service line development, care coordination and quality efforts in all 12 of Spectrum’s hospitals and care sites, the hospital group said in a statement.

“Dr. Elmouchi has played a vital role in Spectrum Health’s cardiovascular program for years and demonstrated his expertise as an excellent physician as well as an effective leader,” said Tina Freese-Decker, president of Spectrum Health Hospital Group, in a statement. “We value his ability to build relationships, understand complex issues and implement key decisions.”

In addition to taking on the new role, Elmouchi will continue teaching medicine at Michigan State University’s College of Human Medicine.

Prior to Spectrum, Elmouchi was a cardiac electrophysiologist at West Michigan Heart and held clinical positions at the University of Michigan Health System and the University of California, San Francisco.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.